Biogen Inc
LSE:0R1B

Watchlist Manager
Biogen Inc Logo
Biogen Inc
LSE:0R1B
Watchlist
Price: 162.27 USD -1.3% Market Closed
Market Cap: 23.7B USD

Wall Street
Price Targets

0R1B Price Targets Summary
Biogen Inc

Wall Street analysts forecast 0R1B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0R1B is 191.7 USD with a low forecast of 143.27 USD and a high forecast of 270.81 USD.

Lowest
Price Target
143.27 USD
12% Downside
Average
Price Target
191.7 USD
18% Upside
Highest
Price Target
270.81 USD
67% Upside
Biogen Inc Competitors:
Price Targets
SAVA
Cassava Sciences Inc
156% Upside
RLMD
Relmada Therapeutics Inc
159% Upside
CSGP
CoStar Group Inc
32% Upside
CDNA
CareDx Inc
21% Upside

Revenue
Forecast

5% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

Operating Income
Forecast

2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
2% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

Net Income
Forecast

2% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
19%
Average Beat
2% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
19%
Average Beat

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0R1B's stock price target?
Price Target
191.7 USD

According to Wall Street analysts, the average 1-year price target for 0R1B is 191.7 USD with a low forecast of 143.27 USD and a high forecast of 270.81 USD.

What is Biogen Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Biogen Inc's revenue is 5%. The projected CAGR for the next 4 years is 0%.

What is Biogen Inc's Operating Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Biogen Inc's operating income is 2%. The projected CAGR for the next 4 years is 4%.

What is Biogen Inc's Net Income forecast?
Projected CAGR
11%

For the last 13 years the compound annual growth rate for Biogen Inc's net income is 2%. The projected CAGR for the next 4 years is 11%.

Back to Top